| Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease TL Edwards, WK Scott, C Almonte, A Burt, EH Powell, GW Beecham, ... Annals of human genetics 74 (2), 97-109, 2010 | 571 | 2010 |
| Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder BF Boeve, MH Silber, TJ Ferman, SC Lin, EE Benarroch, AM Schmeichel, ... Sleep medicine 14 (8), 754-762, 2013 | 434 | 2013 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 429 | 2012 |
| Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–responsive cervical dystonia A Brashear, MF Lew, DD Dykstra, CL Comella, SA Factor, RL Rodnitzky, ... Neurology 53 (7), 1439-1439, 1999 | 404 | 1999 |
| A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease IH Richard, MP McDermott, R Kurlan, JM Lyness, PG Como, N Pearson, ... Neurology 78 (16), 1229-1236, 2012 | 392 | 2012 |
| Visuospatial impairment in Parkinson's disease BE Levin, MM Llabre, S Reisman, WJ Weiner, J Sanchez-Ramos, ... Neurology 41 (3), 365-365, 1991 | 371 | 1991 |
| A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit MF Beal, D Oakes, I Shoulson, C Henchcliffe, WR Galpern, R Haas, ... JAMA neurology 71 (5), 543-552, 2014 | 299 | 2014 |
| Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia MF Lew, BT Adornato, DD Duane, DD Dykstra, SA Factor, JM Massey, ... Neurology 49 (3), 701-707, 1997 | 289 | 1997 |
| Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized … MC Kurth, CH Adler, M St. Hilaire, C Singer, C Waters, P LeWitt, ... Neurology 48 (1), 81-87, 1997 | 285 | 1997 |
| Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double‐blind, placebo‐controlled study D Truong, DD Duane, J Jankovic, C Singer, LC Seeberger, CL Comella, ... Movement disorders: official journal of the Movement Disorder Society 20 (7 …, 2005 | 270 | 2005 |
| Expanded and independent validation of the movement disorder society–unified Parkinson’s disease rating scale (MDS-UPDRS) P Martinez-Martin, C Rodriguez-Blazquez, M Alvarez-Sanchez, T Arakaki, ... Journal of neurology 260, 228-236, 2013 | 259 | 2013 |
| Gait abnormality in essential tremor C Singer, J Sanchez‐Ramos, WJ Weiner Movement disorders 9 (2), 193-196, 1994 | 243 | 1994 |
| Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the … CH Schenck, JY Montplaisir, B Frauscher, B Hogl, JF Gagnon, R Postuma, ... Sleep medicine 14 (8), 795-806, 2013 | 233 | 2013 |
| National randomized controlled trial of virtual house calls for Parkinson disease CA Beck, DB Beran, KM Biglan, CM Boyd, ER Dorsey, PN Schmidt, ... Neurology 89 (11), 1152-1161, 2017 | 210 | 2017 |
| Autonomic dysfunction in men with Parkinson’s disease C Singer, WJ Weiner, JR Sanchez-Ramos European neurology 32 (3), 134-140, 1992 | 200 | 1992 |
| Psychogenic tremors W Koller, A Lang, B Vetere-Overfield, L Findley, L Cleeves, S Factor, ... Neurology 39 (8), 1094-1094, 1989 | 199 | 1989 |
| Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial S Frank, CM Testa, D Stamler, E Kayson, C Davis, MC Edmondson, ... Jama 316 (1), 40-50, 2016 | 186 | 2016 |
| Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis C Dobson-Stone, A Danek, L Rampoldi, RJ Hardie, RM Chalmers, ... European Journal of Human Genetics 10 (11), 773-781, 2002 | 179 | 2002 |
| Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ... Jama 313 (6), 584-593, 2015 | 176 | 2015 |
| Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study M Sun, JC Latourelle, GF Wooten, MF Lew, C Klein, HA Shill, LI Golbe, ... Archives of neurology 63 (6), 826-832, 2006 | 174 | 2006 |
